Omeros Corporation OMER
$9.28
▼ -14.15% 24H
About
Omeros Corporation is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing small-molecule and protein therapeutics. It targets large-market opportunities as well as orphan indications, particularly in areas such as inflammation, coagulopathies, disorders of the central nerv…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees202
TickerOMER
Statistics
Market Cap$668.1M
Revenue (TTM)$9.0M
Net Income-$3.4M
Net Margin-37.3%
EPS$-0.05
P/E8.93
P/S74.47
P/B-9.92
EV/EBITDA-7.95
ROE2.8%
Dividend Yield—
Price$9.28
Data: Twelve Data · Revenue = mcap / P/S